Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioVaxys Technology Corp.
C.BIOV
Alternate Symbol(s):
BVAXF
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical...
-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:BIOV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(4)
•••
mtgfree1
X
Post by
mtgfree1
on Dec 05, 2024 3:38pm
Just a play , look out
No point to say more in my view
(13)
•••
frankman
X
Post by
frankman
on Dec 05, 2024 10:19am
I see my .06 bid on the order depth chart moving up/ L2 ord
I am going to enter a second bid for my trading shares (not many maybe 40k shares alltogether) closer to months end as tax loss season comes to an end. There should be a couple more news updates by
...more
(13)
•••
frankman
X
Post by
frankman
on Dec 05, 2024 8:55am
Full news release
DPX Formulations Superior to Mixing with Commonly Used Adjuvants DPX Without Antigen Cargo Has Immune Stimulating Properties Unique Potential for DPX in New Fields of Use VANCOUVER, BC, Dec
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 05, 2024 7:00am
New Press Release - BioVaxys Shares New Data on its DPX(TM) Immune Educating Platform at Personalized Cancer Vaccine Summit
DPX Formulations Superior to Mixing with Commonly Used Adjuvants DPX Without Antigen Cargo Has Immune Stimulating PropertiesUnique Potential for DPX in New Fields of UseVANCOUVER, BC, Dec. 5, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the Company"...
read article.
•••
Trevor Abes
X
Post by
Trevor Abes
on Dec 04, 2024 4:31pm
Buzz on the Bullboards: Tangible growth stocks
This week, Canada’s main stock index, the TSX, hit a record high thanks to gains in technology and bank stocks.
read article.
(38)
•••
Hideaway
X
Comment by
Hideaway
on Dec 03, 2024 4:00pm
RE:Recovery and Growth: $BIOV and $BOLT.CN
Without a partner with a big pharma and not a lot of cash,BIOV will have a difficult time conducting a clinical trial imo.
(13)
•••
frankman
X
Post by
frankman
on Dec 02, 2024 10:14am
50 percent minimum to 100 ~ percent to March 2025 L2 bid ask
Ask 0.085 30,000 4 0.08 24,000 4 0.075 48,000 5 0.07 52,000 5 0
...more
(13)
•••
frankman
X
Post by
frankman
on Dec 02, 2024 10:08am
Still expect a 50 percent increase in s/p to March 2025
Still haven’t bought my year-end trading shares with roughly 18 trading days left yet. Waiting to see how low I can steal. "Expect a 50% increase in stock price into March 2025 roughly a double
...more
(13)
•••
frankman
X
Post by
frankman
on Nov 26, 2024 3:40pm
Level 2 bid ask 3:40
Ask 0.085 29,000 3 0.08 26,000 4 0.075 48,028 5 0.07 97,000 4 0
...more
(13)
•••
frankman
X
Post by
frankman
on Nov 26, 2024 2:23pm
Current bid ask level 2
Ask 0.085 29,000 3 0.08 26,000 4 0.075 47,000 4 0.07 97,000 4 0
...more
(13)
•••
frankman
X
Post by
frankman
on Nov 26, 2024 2:21pm
1 million shares CDN traded /OTC $US traded 1/2 mil
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr ATS 217.0 0.06 · 0.065
...more
(13)
•••
frankman
X
Post by
frankman
on Nov 26, 2024 12:25pm
Wonder if CEO Passin will participate again in this pp
CEO Passin bought 6 million shares of a previous financing ($300k 09/11 news release). He holds 19 mil~ shares. Current pp .07 with .15 warrants “James Passin, chief executive
...more
(13)
•••
frankman
X
Post by
frankman
on Nov 26, 2024 10:50am
Ooooh .06 can we see .04 or .03? Current bid and ask
As I said looking for some trading shares by year-end. Could we see .045 or lower please? Last time I picked up shares at .04 and .05. Ask 0.085 29,000 3
...more
(13)
•••
frankman
X
Post by
frankman
on Nov 25, 2024 2:39pm
Current bid ask
Ask 0.085 29,000 3 0.08 26,000 4 0.075 57,825 5 0.07 52,000 4 0
...more
(13)
•••
frankman
X
Post by
frankman
on Nov 25, 2024 11:07am
7,340,000 million .20 warrants have expired unexercised
August 25, 2024 0.20 2,000,000 September 19, 2024 0.20 1,350,000 November 10, 2024
...more
(38)
•••
Hideaway
X
Post by
Hideaway
on Nov 23, 2024 12:12pm
NR
VANCOUVER, BC , Nov. 18, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce that it intends to
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Unique Battery Metals opportunity in Quebec
Discover Options Trading Strategies to Minimize your Tax Burden
Rig Count Soars as Utilization Surpasses Industry Averages
Are PGM mining stocks an attractive area for your next portfolio allocation?
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth
Learn How this Company is Disrupting Point-of-Care Testing